keratitis
Information
- Disease name
- keratitis
- Disease ID
- DOID:4677
- Description
- "A corneal disease that is characterized by inflammation of the cornea." [url:http\://www.mayoclinic.org/diseases-conditions/keratitis/basics/definition/con-20035288]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes | Mutation | Description | Source | Links |
---|
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT00001648 | Completed | Structure of the Herpes Simplex Virus Receptor | August 20, 1997 | April 13, 2010 | |
NCT00001734 | Completed | Screening for NEI Clinical Studies | March 23, 1998 | October 3, 2008 | |
NCT00008541 | Completed | Evaluation and Treatment of Patients With Corneal and External Diseases | January 2, 2001 | March 6, 2009 | |
NCT00949468 | Completed | Microbiological Keratitis in a Countryside City of Brazil | June 2008 | July 2009 | |
NCT01028027 | Completed | Phase 3 | Loteprednol and Tobramycin Versus Tobramycin and Dexamethasone, in the Treatment of Blepharokeratoconjunctivitis | October 2009 | March 2010 |
NCT01268306 | Completed | Phase 4 | Study of the Presence and Extent of Corneal Disturbance Associated With B+L Biotrue MPS Used With B+L PureVision Lenses | October 2010 | December 2010 |
NCT01272271 | Completed | Safety of Overnight Corneal Reshaping Lenses | February 2008 | October 2010 | |
NCT01756456 | Completed | Phase 1/Phase 2 | Evaluation of Safety and Efficacy of rhNGF in Patients With Stage 2 and 3 Neurotrophic Keratitis. | January 2013 | May 2016 |
NCT01794312 | Completed | Phase 3 | Efficacy and Safety Assessment of T4020 Versus Vehicule in Patients With Chronic Neurotrophic Keratitis or Corneal Ulcer | February 2013 | December 19, 2017 |
NCT02151305 | Completed | N/A | Different Hemostasis According to the Anesthetic Agents | August 2010 | April 2012 |
NCT02186431 | Completed | N/A | Contact Lenses and Infiltrative Keratitis | July 2014 | May 2016 |
NCT02293876 | Completed | N/A | Corneal Lesions in Intensive Care Unit (ICU) Clinical Trial for Proposing Interventions and Evaluating Outcomes of Nursing in the Adult Intensive Care Center Clinical Trial for Proposing Interventions and Evaluating Outcomes of Nursing in the Adult Intensive Care Center | April 2013 | November 2014 |
NCT03237936 | Completed | Phase 4 | Effect of IKERVIS® Eye Drops Once Daily on the Quality of Vision in Dry Eye Disease Patients With Severe Keratitis | March 28, 2017 | July 11, 2018 |
NCT03586505 | Completed | N/A | Tolerance to Light for Patients Suffering From Keratitis | July 3, 2018 | August 7, 2019 |
NCT03706443 | Completed | N/A | Tear Lipid Layer Thickness Changes With Use of Emollient and Non-Emollient Eye Drops | December 5, 2018 | February 28, 2019 |
NCT04169061 | Completed | Phase 4 | Impact of Acthar on Everyday Life of Participants With Severe Keratitis | November 13, 2019 | December 7, 2020 |
NCT05538793 | Completed | Deep Learning for the Discrimination Among Different Types of Keratits: a Nationwide Study | July 1, 2020 | October 20, 2023 | |
NCT06070883 | Completed | N/A | Efficacy of Mutilayered Fresh Amnoitic Membrane Transplantation in Resistant Fungal Keratitis | January 1, 2022 | October 1, 2023 |
NCT00513734 | Completed | N/A | A Comparison of Hydrogel Dressings and Ocular Lubricants in the Prevention on Corneal Damage in the Critically Ill | September 2004 | February 2005 |
NCT00732446 | Completed | Phase 3 | Safety/Efficacy of Antibiotic Steroid Combination in Treatment of Blepharitis and/or Keratitis and/or Conjunctivitis | August 2008 | February 2009 |
NCT05689996 | Not yet recruiting | Phase 3 | Ozone-based Eye Drops as Adjuvant Therapy in Microbial Keratitis | January 2023 | May 1, 2023 |
NCT04420962 | Recruiting | Automated Quantitative Ulcer Analysis Study | July 23, 2020 | July 2024 | |
NCT05183906 | Recruiting | Evaluation of Next-Generation Sequencing-based Metabarcoding Versus Culturing for Microbiological Assessment in Infectious Keratitis | December 9, 2021 | June 1, 2024 | |
NCT05255016 | Recruiting | Phase 2/Phase 3 | Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Refractory Corneal Ulcers | March 14, 2022 | February 24, 2024 |
NCT06229379 | Recruiting | N/A | The Effects of a Large Language Model on Clinical Questioning Skills | September 1, 2023 | June 2024 |
NCT05255107 | Recruiting | Phase 2/Phase 3 | Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Previously Untreated Corneal Ulcers | March 14, 2022 | February 24, 2024 |
NCT05432336 | Recruiting | Complex Ocular Infection, Optimization of Microbiological Diagnosis | November 21, 2023 | May 2025 | |
NCT05250583 | Terminated | Phase 2 | Use of a Biological Lens of Amniotic Membrane (LV-Visio-AMTRIX) in the Treatment of Treatment-Resistant Keratitis | June 29, 2020 | January 7, 2021 |
NCT02116062 | Terminated | N/A | Robotic Surgery of the Ocular Surface | June 2014 | April 2018 |
NCT04075669 | Unknown status | Multiplex Strip Polymerase Chain Reaction for Diagnosis of Eye Infection Diseases From Corneal Scraping Samples | August 1, 2019 | June 2020 | |
NCT02865876 | Unknown status | Phase 3 | Effectiveness of Corneal Accelerated Crosslinking for Infectious Keratitis | June 2015 | March 2017 |
NCT00838422 | Unknown status | Reliability of Pachymetry Measurement With FD-oCT, ORA, Confoscan 4 and Ultrasound | June 2008 | June 2009 | |
NCT03436576 | Unknown status | Phase 3 | Efficacy of Two Concentrations of Autologous Serum for the Treatment of Severe Dry Eye | September 12, 2018 | November 19, 2018 |
NCT00492245 | Unknown status | N/A | Phototherapeutic Keratectomy (PTK) With Mitomycin in Adenoviral Opacities | April 2006 | December 2008 |
NCT01721694 | Withdrawn | Phase 3 | Antibiotic Steroid Combination Compared With Individual Administration in the in the Treatment of Ocular Inflammation and Infection | December 2012 | May 2013 |
- Disase is a (Disease Ontology)
- DOID:10124
- Cross Reference ID (Disease Ontology)
- ICD10CM:H16
- Cross Reference ID (Disease Ontology)
- ICD9CM:370
- Cross Reference ID (Disease Ontology)
- MESH:D007634
- Cross Reference ID (Disease Ontology)
- NCI:C26805
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:193757003
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0022568
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0000491
- ICD10 preferred id (Insert disease from ICD10)
- D0006059
- ICD10 class code (Insert disease from ICD10)
- H16
- MeSH unique ID (MeSH (Medical Subject Headings))
- D007634